276 related articles for article (PubMed ID: 23358684)
1. ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
Swindall AF; Londoño-Joshi AI; Schultz MJ; Fineberg N; Buchsbaum DJ; Bellis SL
Cancer Res; 2013 Apr; 73(7):2368-78. PubMed ID: 23358684
[TBL] [Abstract][Full Text] [Related]
2. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
4. Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.
Alexander KL; Serrano CA; Chakraborty A; Nearing M; Council LN; Riquelme A; Garrido M; Bellis SL; Smythies LE; Smith PD
J Biol Chem; 2020 Oct; 295(41):14153-14163. PubMed ID: 32763973
[TBL] [Abstract][Full Text] [Related]
5. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
[TBL] [Abstract][Full Text] [Related]
6. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
Seales EC; Jurado GA; Brunson BA; Wakefield JK; Frost AR; Bellis SL
Cancer Res; 2005 Jun; 65(11):4645-52. PubMed ID: 15930282
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
[TBL] [Abstract][Full Text] [Related]
8. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.
Swindall AF; Bellis SL
J Biol Chem; 2011 Jul; 286(26):22982-90. PubMed ID: 21550977
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
Lee M; Park JJ; Ko YG; Lee YS
Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
[TBL] [Abstract][Full Text] [Related]
10. The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance.
Cui H; Yang S; Jiang Y; Li C; Zhao Y; Shi Y; Hao Y; Qian F; Tang B; Yu P
Clin Transl Oncol; 2018 Sep; 20(9):1175-1184. PubMed ID: 29423671
[TBL] [Abstract][Full Text] [Related]
11. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
[TBL] [Abstract][Full Text] [Related]
12. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
13. Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells.
Britain CM; Bhalerao N; Silva AD; Chakraborty A; Buchsbaum DJ; Crowley MR; Crossman DK; Edwards YJK; Bellis SL
J Biol Chem; 2021; 296():100034. PubMed ID: 33148698
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
15. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen.
Korekane H; Matsumoto A; Ota F; Hasegawa T; Misonou Y; Shida K; Miyamoto Y; Taniguchi N
J Biochem; 2010 Sep; 148(3):359-70. PubMed ID: 20656882
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD133 correlates with differentiation of human colon cancer cells.
Feng HL; Liu YQ; Yang LJ; Bian XC; Yang ZL; Gu B; Zhang H; Wang CJ; Su XL; Zhao XM
Cancer Biol Ther; 2010 Feb; 9(3):216-23. PubMed ID: 20023382
[TBL] [Abstract][Full Text] [Related]
18. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
[TBL] [Abstract][Full Text] [Related]
19. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
Munro MJ; Peng L; Wickremesekera SK; Tan ST
PLoS One; 2020; 15(5):e0232934. PubMed ID: 32428045
[TBL] [Abstract][Full Text] [Related]
20. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
